Individual participant data meta-analyses should not ignore clustering

Research output: Contribution to journalArticlepeer-review

Authors

  • Ghada Abo-Zaid
  • Thomas P A Debray
  • Ewout W Steyerberg
  • Karel G M Moons

Colleges, School and Institutes

Abstract

OBJECTIVES: Individual participant data (IPD) meta-analyses often analyze their IPD as if coming from a single study. We compare this approach with analyses that rather account for clustering of patients within studies.

STUDY DESIGN AND SETTING: Comparison of effect estimates from logistic regression models in real and simulated examples.

RESULTS: The estimated prognostic effect of age in patients with traumatic brain injury is similar, regardless of whether clustering is accounted for. However, a family history of thrombophilia is found to be a diagnostic marker of deep vein thrombosis [odds ratio, 1.30; 95% confidence interval (CI): 1.00, 1.70; P = 0.05] when clustering is accounted for but not when it is ignored (odds ratio, 1.06; 95% CI: 0.83, 1.37; P = 0.64). Similarly, the treatment effect of nicotine gum on smoking cessation is severely attenuated when clustering is ignored (odds ratio, 1.40; 95% CI: 1.02, 1.92) rather than accounted for (odds ratio, 1.80; 95% CI: 1.29, 2.52). Simulations show models accounting for clustering perform consistently well, but downwardly biased effect estimates and low coverage can occur when ignoring clustering.

CONCLUSION: Researchers must routinely account for clustering in IPD meta-analyses; otherwise, misleading effect estimates and conclusions may arise.

Bibliographic note

Copyright © 2013 Elsevier Inc. All rights reserved.

Details

Original languageEnglish
Pages (from-to)865-873.e4
JournalJournal of Clinical Epidemiology
Volume66
Issue number8
Publication statusPublished - Aug 2013

Keywords

  • Adult, Age Factors, Bias (Epidemiology), Brain Injuries, Cluster Analysis, Confidence Intervals, Data Interpretation, Statistical, Humans, Meta-Analysis as Topic, Models, Statistical, Odds Ratio, Prognosis, Randomized Controlled Trials as Topic, Smoking Cessation, Thrombophilia, Tobacco Use Cessation Products, Venous Thrombosis

Sustainable Development Goals